Who we are
We are one of the fastest growing companies operating on the pharmaceutical market and focused on creating innovative formulas and solutions in dermatology, paediatrics and cough and cold. More ›Aktualności
-
Press release: Consolidated Financial Results of the Nepentes Group for the First Half of 2010
The market’s weaker growth dynamics in H1 2010 did not prevent Nepentes from strengthening the market…
31.08.2010 16:50
-
Press release: Polish Office of Competition and Consumer Protection Approves Acquisition of Nepentes by Sanofi-Aventis
On July 1st 2010, the President of the Polish Office of Competition and Consumer Protection (UOKiK) approved a…
05.07.2010 12:00
Relacje inwestorskie
-
Exclusion of Nepentes Stock from the WIG and WIG-PL Indices
Announcement of the Management Board of the Warsaw Stock Exchange (the Main Market of the WSE) »
24.08.2010 16:52
Bieżący kurs akcji:
07.09.2010
27.70 PLN 0% 0 PLN